Surrogate End Points for the Treatment of Diabetic Neuropathic Foot Ulcers
Open Access
- 1 June 2003
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 26 (6) , 1696-1700
- https://doi.org/10.2337/diacare.26.6.1696
Abstract
OBJECTIVE—The goal of this study was to determine whether surrogate markers based primarily on changes in the size of a wound can be used to correctly predict which individuals with diabetic neuropathic foot ulcers will heal after 12 or 20 weeks of care.Keywords
This publication has 23 references indexed in Scilit:
- Surrogate Endpoints for the Treatment of Venous Leg UlcersJournal of Investigative Dermatology, 2002
- Surrogate endpoints: the debate goes onPharmacoepidemiology and Drug Safety, 2001
- The use of surrogate endpoints in clinical trials: focus on clinical trials in cardiovascular diseasesPharmacoepidemiology and Drug Safety, 2001
- Guidance for industry: Chronic cutaneous ulcer and burn wounds—developing products for treatmentWound Repair and Regeneration, 2001
- Consensus Development Conference on Diabetic Foot Wound Care: 7-8 April 1999, Boston, Massachusetts. American Diabetes Association.Diabetes Care, 1999
- Initial rate of healing predicts complete healing of venous ulcersArchives of Dermatology, 1997
- The Covariance Decomposition of the Probability Score and Its Use in Evaluating Prognostic EstimatesMedical Decision Making, 1995
- Venous leg ulcers: an analysis of underlying venous diseaseBritish Journal of Dermatology, 1993
- Planimetric rate of healing in venous ulcers of the leg treated with pressure bandage and hydrocolloid dressingJournal of the American Academy of Dermatology, 1993
- Chronology and determinants of tissue repair in diabetic lower-extremity ulcersDiabetes, 1991